Fortune Brands Innovations and Augury Forge a New Standard for Trusted AI in Manufacturing
NEW YORK & DEERFIELD, Ill.--(BUSINESS WIRE)-- Augury, a leader in AI solutions for reliability and process optimization that help industrial companies increase operation-wide productivity, and Fortune Brands Innovations Inc. (NYSE: FBIN), an industry-leading innovation company whose purpose is to elevate every life by transforming spaces into havens, today announced the results of Fortune Brands Innovations' seamless deployment of Augury's full-stack Machine Health solution at its Fiberon sites and on-going enterprise-wide rollout across 1,000+ machines internationally.
As part of their collaboration, the companies have shared details with Bloomberg Originals about how cutting-edge AI capabilities are reshaping the future of manufacturing. The video, which is an episode within the Genbiz Video Series, can be found here: https://www.bloomberg.com/news/videos/2025-05-02/how-ai-might-reshape-factories-video
'At Fortune Brands Innovations, innovation is core to everything we do. But as a global manufacturer of home and security products that millions count on to make their homes and commercial buildings safe, beautiful, and functional, there is no room for error on our factory floors. Every technology we deploy must be fully trusted,' said Todd Piatt, VP, Global Manufacturing Operations. 'That trust was built quickly as we saw the accuracy of Augury's AI firsthand and experienced the team's responsive, collaborative support, laying the groundwork for a 2.5x ROI during the pilot. The AI strategy we've continuously built in partnership with Augury has amplified these measurable results. Augury consistently delivers unparalleled visibility into our equipment health and performance, and the digital transformation we're powering together will revolutionize our operations into a truly proactive, resilient system.'
To boost uptime, increase capacity, extend equipment lifecycles and reduce the cost of asset care, Fortune Brands Innovations turned to Augury's Machine Health solution, an industrial-grade IoT and AI platform trained on the world's largest data library. Augury's full-stack solutions use sensors that capture vibration, temperature, and magnetic data from machines; advanced AI diagnostics; and human reliability experts to improve the health and performance of industrial assets.
The partnership began with a pilot at Fortune Brands Innovations' Fiberon facility in North Carolina, where 40 machines were connected to Augury's AI. After achieving 2.5x ROI in just eight months, the success of the pilot led Fortune Brands Innovations to leverage Augury's Fast Track methodology for a 12-month enterprise-wide rollout. Now at the halfway mark, Augury's Machine Health solution is already deployed on two-thirds of the 1,000 machines targeted across 16 sites in the U.S., UK, and Mexico.
'Implementing Augury's predictive maintenance solution has been a game-changer for our Fiberon operations,' said Pat Knox, Machine Health Program Owner and Director of Manufacturing Intelligence Systems at Fortune Brands Innovations. 'There are a lot of predictive maintenance solutions out there that make empty promises – solutions that require heavy upfront investment – yet they rarely deliver. Augury was different. Early in the pilot, it helped us prevent a catastrophic melt-pump failure, which set the stage for a 2.5 times payback. This fast time-to-value, combined with Augury's seamless integration into every level of our technology stack, made the decision to scale across 16 plants a no-brainer. Augury has truly transformed the way we approach maintenance, ensuring our equipment runs at peak performance.'
'It's inspiring to see how much Fortune Brands Innovations has been able to accomplish on the digital transformation front,' said Saar Yoskovitz, co-founder and CEO of Augury. 'The entire business has embraced a culture of tech innovation and proven the value of data-driven decision making with benefits across the organization – from asset health and lifespan improvements to team engagement and energizing frontline adoption. Augury is proud to be a part of those accomplishments.'
As global manufacturers navigate market volatility, Fortune Brands Innovations charts a different path. By tapping into a bold digital transformation strategy, the company delivers tangible impact across its bottom-line, strengthens its supply chain and ensures the consistent delivery of high-quality products to its customers. Its strategic approach to scaling AI offers a compelling blueprint industrial leaders can use to avoid pilot purgatory and truly futureproof their factories.
Learn more about how Augury is helping manufacturers unlock production predictability here.
About Augury
A leader in Machine Health and Process Health solutions, Augury uses purpose-built AI technology, trained by industry experts and the world's largest data library, to help manufacturing and industrial companies eliminate production downtime, improve process efficiency, maximize yield, and reduce waste and emissions. Our global customers achieve 5-20x ROI, often in a matter of months. Together with our customers, we are pioneering Production Health to transform how people and machines work together to push the boundaries of human productivity.
For more information, visit www.augury.com
About Fortune Brands Innovations
Fortune Brands Innovations, Inc. is an industry-leading innovation company dedicated to creating smarter, safer and more beautiful homes and improving lives. The Company's driving purpose is to elevate every life by transforming spaces into havens.
The Company is a brand, innovation and channel leader focused on exciting, supercharged categories in the home products, security and commercial building markets. The Company's portfolio of brands includes Moen, House of Rohl, Aqualisa, SpringWell, Therma-Tru, Larson, Fiberon, Master Lock, SentrySafe and Yale residential.
Fortune Brands is headquartered in Deerfield, Illinois and trades on the NYSE as FBIN. To learn more, visit www.FBIN.com.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Business Insider
23 minutes ago
- Business Insider
Evercore ISI Reaffirms Their Buy Rating on Charles River Labs (CRL)
Evercore ISI analyst Elizabeth Anderson CFA maintained a Buy rating on Charles River Labs (CRL – Research Report) yesterday and set a price target of $170.00. The company's shares closed yesterday at $143.22. Confident Investing Starts Here: Anderson CFA covers the Healthcare sector, focusing on stocks such as CVS Health, Align Tech, and Quest Diagnostics. According to TipRanks, Anderson CFA has an average return of -6.7% and a 42.08% success rate on recommended stocks. In addition to Evercore ISI, Charles River Labs also received a Buy from Redburn Atlantic's Jamie Clark in a report issued on May 23. However, on June 3, William Blair maintained a Hold rating on Charles River Labs (NYSE: CRL). Based on Charles River Labs' latest earnings release for the quarter ending March 29, the company reported a quarterly revenue of $984.17 million and a net profit of $25.47 million. In comparison, last year the company earned a revenue of $1.01 billion and had a net profit of $67.33 million Based on the recent corporate insider activity of 54 insiders, corporate insider sentiment is negative on the stock. This means that over the past quarter there has been an increase of insiders selling their shares of CRL in relation to earlier this year. Last month, Joseph W LaPlume, the EVP, Corp Strategy & Develop of CRL sold 500.00 shares for a total of $72,705.00.
Business Insider
23 minutes ago
- Business Insider
Leerink Partners Sticks to Its Buy Rating for Universal Health (UHS)
In a report released yesterday, Whit Mayo from Leerink Partners maintained a Buy rating on Universal Health (UHS – Research Report), with a price target of $252.00. The company's shares closed yesterday at $188.65. Confident Investing Starts Here: Mayo covers the Healthcare sector, focusing on stocks such as Humana, Pediatrix Medical Group, and Tenet Healthcare. According to TipRanks, Mayo has an average return of 2.9% and a 49.75% success rate on recommended stocks. In addition to Leerink Partners, Universal Health also received a Buy from Wells Fargo's Stephen Baxter in a report issued on May 29. However, yesterday, Morgan Stanley maintained a Hold rating on Universal Health (NYSE: UHS). Based on Universal Health's latest earnings release for the quarter ending March 31, the company reported a quarterly revenue of $4.1 billion and a net profit of $316.68 million. In comparison, last year the company earned a revenue of $3.84 billion and had a net profit of $261.83 million Based on the recent corporate insider activity of 51 insiders, corporate insider sentiment is negative on the stock. This means that over the past quarter there has been an increase of insiders selling their shares of UHS in relation to earlier this year. Last month, Maria Singer Ruderman, a Director at UHS sold 1,097.00 shares for a total of $210,042.59.
Business Insider
23 minutes ago
- Business Insider
Leerink Partners Sticks to Its Buy Rating for HCA Healthcare (HCA)
Leerink Partners analyst Whit Mayo maintained a Buy rating on HCA Healthcare (HCA – Research Report) yesterday and set a price target of $420.00. The company's shares closed yesterday at $381.66. Confident Investing Starts Here: Mayo covers the Healthcare sector, focusing on stocks such as Humana, Pediatrix Medical Group, and Tenet Healthcare. According to TipRanks, Mayo has an average return of 2.9% and a 49.75% success rate on recommended stocks. In addition to Leerink Partners, HCA Healthcare also received a Buy from Barclays's Andrew Mok CFA in a report issued on June 3. However, on May 29, Wells Fargo upgraded HCA Healthcare (NYSE: HCA) to a Hold. Based on HCA Healthcare's latest earnings release for the quarter ending March 31, the company reported a quarterly revenue of $18.32 billion and a net profit of $1.61 billion. In comparison, last year the company earned a revenue of $17.34 billion and had a net profit of $1.59 billion Based on the recent corporate insider activity of 59 insiders, corporate insider sentiment is negative on the stock. This means that over the past quarter there has been an increase of insiders selling their shares of HCA in relation to earlier this year. Last month, Jon Foster, the EVP & COO of HCA sold 15,698.00 shares for a total of $5,797,585.36.
